Experimental injection tested for severe lung failure
NCT ID NCT07319351
Summary
This study tested an experimental injection called TISA-818-Inj in patients with Acute Respiratory Distress Syndrome (ARDS), a severe lung condition often requiring breathing machines. Fifty-seven adults with ARDS from pneumonia received either the drug or a placebo for 14 days. Researchers measured safety and whether the treatment helped patients spend fewer days on breathing support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
Conditions
Explore the condition pages connected to this study.